Search for: "HOWE v. WYETH" Results 1 - 20 of 645
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2024, 9:50 am by Jonathan H. Adler
More importantly, when the FDA approves a medication, this does not immunize the manufacturer against tort liability, as cases such as Wyeth v. [read post]
8 Dec 2023, 7:58 am by Timothy Bonis
The Federal Circuit demanded full scope enablement in biological and chemical fields before Amgen (see Wyeth & Cordis Corp. v. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
4 Nov 2022, 9:13 am
As well as how manufacturers can avoid liability for even the dangerous use of their products. [read post]
30 Mar 2022, 7:01 pm by Sean Wajert
  Albrecht, of course, clarified some of the language in Wyeth v. [read post]
17 May 2021, 12:45 am by Annsley Merelle Ward
Kleemans in Dutch here.It remains to be seen whether this case will be appealed and if so, how the Court of Appeal deals with this issue. [read post]
29 Mar 2021, 7:10 pm by admin
Determining how much overlap makes the sharing harmful of confidential information has proceeded on a case-by-case basis. [read post]
23 Dec 2020, 5:31 am by Annsley Merelle Ward
In IPCom v HTC [2020] EWHC 2941 (Pat), IPCom sought to plead a similar point but Birss J took a harder line. [read post]
2 Nov 2020, 2:00 am by Emma Irwin (Bristows)
Wyeth referred Meade J. to the Idenix v Gilead and KCI v Smith & Nephew cases when making its submissions on the principles of the law on CGK. [read post]
28 May 2020, 5:29 am by Schachtman
The judicial “weight not admissibility” label conveys the denial of the challenge, but it hardly explains how and why the challenge failed under Rule 702. [read post]